急性脑梗死患者联合检测hs-CRP、Hcy及血小板的应用价值

摘要

Objective To investigate the application value of hypersensitive C-reactive protein (hs-CRP) , serum homocysteine( Hcy) , platelet( PLT) for diagnosing and treating patients with acute cerebral infarction. Methods A statistical analysis was performed on the results of the combined detection hs-CRP,Hcy and platelet before and after treatment of patient with acute cerebral infarction and on healthy control group respectively. Results In comparison with healthy control group, PLT of acute cerebral infarction group decreased significantly before treatment(P <0.05) , Hey and hs-CRP increased significantly. After treatment, PLT increased, Hey and hs-CRP decreased, compared with healthy controls, showed no statistical significance ( P >0. 05 ). Conclusion The assays of analyzing serum Hcy,hs-CRP levels and PLT were important to learn the severity and outcome in patients with acute cerebral infarction,which have some reference value in the diagnosis, treatment and prognosis judgment on clinically.%目的 探讨检测超敏C反应蛋白(hs-CRP)、血清同型半胱氨酸(Hey)、血小板(PLT)在急性脑梗死患者中的诊断与治疗价值.方法 对急性脑梗死患者治疗前后组和健康对照组进行hs-CRP、Hcy及血小板联合检测,并对检测结果进行统计学分析.结果 与健康对照组比较,急性脑梗死组治疗前血小板明显减少(P＜0.05),Hcy及hs-CRP明显升高；治疗后PLT升高,Hcv及hs-CRP下降,与健康对照组比较差异无统计学意义(P＞0.05).结论 测定血清Hcv、hs-CRP水平及监测PLT,是了解急性脑梗死病情严重程度及预后的重要指标,在临床诊断、治疗与预后判断等均有一定的参考价值.